Please use the links to the left to find out more about us.


Sunday September 17, 2017

On Sunday September 17, 2017, you will have two chances to hear Trio La Milpa perform Viet Cuong’s Suite for Two Oboes and English horn, one the group’s signature works. Praised by the New York Times and the Philadelphia Inquirer, along with numerous musical publications, Viet Cuong has become one of the most influential young composers of our time. A graduate of Princeton University and currently enrolled in Curtis Institute’s Artist Diploma program, Viet Cuong was the winner of the 2009 Peabody/Trio La Milpa Composition Competition and the 2013 ASCAP Morton Gould Young Composers’ Award for his Suite. Trio La Milpa premiered the work in May 2009 and performed it at the 2011 International Double Reed Society Conference in Scottsdale, Arizona.

Come hear Trio La Milpa perform Viet Cuong’s Suite on September 17 at 3pm, 7:30pm, or both! 3pm in Catonsville, 7:30 in Baltimore. More information on the links below. See you there! Twice?

Featuring works by Handel, Viet Cuong, and much more!

StoredIQ ink pact to provide a eDiscovery platform CaseCentral.

‘By partnering with StoredIQ, our customers can create end-to-end, streamlined eDiscovery processes, reducing both cost and risk.’ ‘This partnership combines two proven technologies that span the entire electronic discovery life cycle,’ said Ursula Talley, vice president of marketing at StoredIQ. ‘Enterprises reap the advantage of a faster, more efficient discovery process, while making sure the integrity of data and chain of custody throughout.’.. CaseCentral, StoredIQ ink pact to provide a eDiscovery platform CaseCentral, the first choice in secure, on-demand eDiscovery software for corporate counsel and lawyers looking to simplify and manage eDiscovery, and StoredIQ, a respected provider of Intelligent Information Management and eDiscovery technologies, announced a strategic partnership to supply an integrated eDiscovery supplying that ranges from identification today, preservation, collection and processing of electronically stored info through analysis, review, production and post-production re-use. Continue reading

Passive ventilation significantly increases survival rates www.malegra.net.

Assisted ventilation in cardiac arrest rescue might lower chances of survival Arizona experts have added another piece to the installation body of evidence that suggests during resuscitation attempts to treat sufferers in cardiac arrest, passive ventilation significantly increases survival rates, when compared to widely practiced assisted ventilation. The scholarly study, published in an on-line edition of Annals of Crisis Medicine, compared the numbers of patients who had experienced a cardiac arrest outside a medical center setting and had been resuscitated in the field by Crisis Medical Services employees. Rescuers utilized either bag-valve-mask ventilation, which forces air flow into the patient’s lungs, or facemasks with a continuing stream of oxygen, which function in a similar fashion to those continued airplanes in the event the cabin pressure drops www.malegra.net . Continue reading

Detection and disease monitoring of Lewy body dementias.

Yet many individuals who have LBD are misdiagnosed, mostly with Alzheimer’s or Parkinson’s illnesses. Developing effective biomarkers is key to helping to correctly diagnose the condition, monitor disease progression and develop effective brand-new drugs to treat, prevent and cure LBD. The full total pool of grant money available for fiscal year 2009 is $100,000. Applications might be submitted by non-income academic institutions and for-profit general public and private biotechnology companies. Applications are available at The submission deadline date is November 1, 2009. Applications will become reviewed by an unbiased Scientific Review Committee convened by ADDF and LBDA and made up of leading specialists in the neurodegenerative disease medication discovery and development analysis field and biotechnology expense community. Continue reading

Alnylam second quarter income decreases to $20.

The decrease in G&A expenses for the next quarter of 2011 in comparison with the prior calendar year period was due primarily to a decrease in professional service fees linked to business activities, legal activities primarily. Regulus Therapeutics Collateral in loss of joint venture was $1.0 million and $3.9 million for the next quarter of 2011 and 2010, respectively, related to Alnylam’s share of the web losses incurred by Regulus. Interest Income Interest income was $0.3 million for the second quarter of 2011, as compared to $0.6 million for the next quarter of 2010. The reduction in interest income was due to lower average cash primarily, money equivalents and total marketable securities balances as compared to the last year. Continue reading

These so-called henna products are laced with toxic ingredients and large metals sometimes.

Regrettably, so-called natural henna items often contain hardly any henna, but support the same poisonous substances as much of these dyes. Reactions to PPD A full-blown reaction will not occur after make use of immediately. In many cases, a poor reaction is mild and can sometimes focus on an itchy scalp or body, but as the times move on, it could start to escalate. Sensitization is certainly what triggers the allergic attack. This can result in swelling, and an burning intensely, itching sensation spreading over the skin. Serious reactions to PPD could be urticaria and anaphylaxis, which are both serious types of rashes. An allergic attack has been recognized to put individuals right into a coma; on rare events it has verified fatal. Continue reading

Biocon receives regulatory acceptance for biosimilar product.

This launch additional strengthens our expanding industrial existence in India also, as we enter the oncology and essential treatment segments.’ Trastuzumab is among the five biologic items Mylan is developing together with Biocon for the global industry. Mylan has distinctive commercialization privileges for biosimilar trastuzumab in the U.S., Canada, Japan, Australia, New Zealand and in europe and European Totally free Trade Association countries and co-exclusive commercialization privileges with Biocon for item in India. Mylan expects to release trastuzumab in India early in 2014. Relating to IPSOS, trastuzumab acquired sales in India of around $21 million for the 12 weeks ended Dec. 31, 2012. The Washington Post: CDC Says It Improperly Sent Dangerous Pathogens In Five Incidents In History Decade Authorities laboratories in Atlanta improperly sent potentially deadly pathogens, including anthrax, botulism bacteria and a virulent bird flu virus, to various other laboratories in five split incidents over the past decade, officials said Fri . Continue reading

But it is prematurily.

The operation will demand a large, L-designed incision as both relative heads have to come out simultaneously, along with two pieces of shoulders. Within minutes of their birth, girls will be put into the treatment of a neonatology group led by Dr. Brian Lupton, a Neonatal professional. They have been around in the womb for 34 weeks, this means they will be premature and could need help breathing. Dr. Lupton, says they have got rehearsed the procedures which may be required to focus on two small mouths so close collectively and tools has been altered to cope with the problem, which means there is certainly two of everything and everyone. Continue reading

Offers announced that it provides received 510 clearance from the U.

William Hunter, CEO and President of Angiotech. ‘This is an important milestone inside our Company’s background, and we anticipate getting into the commercial phase of our 5-FU CVC product, in addition to developing other implantable devices that use this novel and proprietary anti-infective technology platform.’ Related StoriesGastric balloon in a tablet helps patients lose excess weight without surgery or endoscopyMycobacterium could be more effective in treating superficial bladder malignancy, study findsMiriam Medical center enrolling local individuals for Parachute implant scientific trial to treat heart failureThe medical data from Angiotech’s 960 patient medical trial comparing its 5-FU CVC with a chlorhexidine/silver sulfadiazine coated CVC was recently presented by clinical investigators at the 28th International Symposium on Intensive Care and Emergency Medication in Brussels. Continue reading


About CVS/pharmacy CVS/pharmacy, the retail division of CVS Wellness , is definitely America's leading retail pharmacy with 7,800 locations. It’s the first national pharmacy to end the sale of tobacco and the initial pharmacy in the country to receive the city Pharmacy accreditation from URAC, the leading healthcare accreditation organization that establishes quality standards for the ongoing healthcare industry. CVS/pharmacy is normally reinventing pharmacy to help people on their path to better health by giving the most accessible and personalized expertise, both in its shops and online at CVS.com. General information regarding CVS/pharmacy and CVS Wellness is available at.. PRESS RELEASE WOONSOCKET, R.I.,Might 19, 2015/PRNewswire/ – – Tocelebrate the unofficial start of summer season, CVS/pharmacy announced the CVSCash Card promotion, a program designed to put a little extra cash in loyal customers' pockets while shopping for everyday essentials at participating CVS/pharmacy locations nationwide. Continue reading

A biopharmaceutical advancement organization.

An interview with Professor Lesley Jones ‘The Precision Spectra Program is a significant milestone in the advancement of SCS therapy,’ stated Maulik Nanavaty, president of the Neuromodulation business at Boston Scientific. ‘Our technology is focused on treatment and the Accuracy Spectra Program demonstrates our dedication to providing improved treatment to a broader spectral range of chronic pain individuals. MAP Trial: A cross-sectional, multicenter research to recognize the prevalence of multiple regions of discomfort in SCS-eligible sufferers with certain diseases. As well as the Precision Spectra Program, the Boston Scientific Neuromodulation business has launched several services and has received extended regulatory indications for items approved in Europe. Included in these are: Head-just MRI Conditional CE Tag Approval for the Accuracy? Plus SCS System Peripheral Nerve Stimulation CE Mark Acceptance for the Accuracy Plus SCS System Vercise? Deep Human brain Stimulator System CE Tag Approval for Parkinson's Disease Infinion? 16 Percutaneous Lead for SCS.. Continue reading